The vaccine is being used on dogs with three types of cancer — osteosarcoma, hemangiosarcoma, and urothelial carcinoma, a form of bladder cancer. Cancer is the top cause of death for dogs.

Mamula and his team are testing the treatment in three types of canine cancer: bladder cancer, osteosarcoma (bone cancer), and hemangiosarcoma, which affects the spleen. After several years of ...

Notably, treatment usage trends from a Bladder Cancer Advocacy Network (BCAN) survey presented at GU ASCO 2025 revealed that only 1–5% of patients reported having seen a radiation oncologist and only ...

Mamula and his team are testing the treatment in three types of canine cancer: bladder cancer, osteosarcoma (bone cancer), and hemangiosarcoma, which affects the spleen. After several years of ...

Dogs share our homes, our habits and sometimes, our diseases. Gastric cancer is rare in dogs, but when it does strike, it ...

From a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments ...

PGV001 vaccine combined with immunotherapy is safe, well-tolerated, and elicits a strong immune response in bladder cancer patients. Personalized vaccines target tumor-specific mutations, enhancing ...

AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...

The next big test is whether using Pluvicto can delay the advancement of prostate cancer enough to delay chemical castration, ...

Bladder cancer is a common cancer and one of the most costly to treat, yet there has been little change in the standard of care in 40 years. This panel will focus on the unmet needs in bladder ...

AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the drug demonstrated benefits in those with a higher-risk form of non ...

Imfinzi is approved for muscle-invasive bladder cancer and is under investigation in various stages and combinations for bladder cancer treatment. Imfinzi plus BCG induction and maintenance therapy ...